American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.
Psychedelic medicine (New Rochelle, N.Y.) March 1, 2024 Brian S Barnett, Miranda Arakelian, David Beebe et al. 28 citations
A repeat survey of American psychiatrists in 2022-23 found a striking increase in optimism about the therapeutic use of hallucinogens compared to 2016. Among 131 respondents (13.1% response rate), 80.9% moderately or strongly believed hallucinogens show promise for psychiatric conditions, and 60.8% for substance use disorders. Large majorities supported research into therapeutic potential (93.9% for psychiatric conditions, 88.6% for substance use disorders) and federal funding of clinical trials. Concern about risks decreased, and 50.4% reported moderate or strong intentions to incorporate hallucinogen-assisted therapy into their practice if regulatory approval is granted.